"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
- Clinician Information:
Normocarb HF Side Effects Center
Medical Editor: John Cunha, DO, FACOEP
Normocarb HF (sodium chloride/magnesium chloride hexahydrate/sodium bicarbonate) is used for adults and children for Continuous Renal Replacement Therapy (CRRT) as a replacement solution in hemofiltration or hemodiafiltration. Side effects can result for the solution of the CRRT procedure. Improper use can lead to fluid imbalance and disturbances in electrolyte, acid-base and glucose balance.
Normocarb is administered in a clinical setting and a physician determines dose. Normocarb may interact with filterable/dialyzable drugs, cardiac glycoside medications, or citrates. Tell your doctor all medications you use. There is no data available concerning use of Normocarb HF in pregnancy and/or breastfeeding.
Our Normocarb HF Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Normocarb HF FDA Prescribing Information: Side Effects
No information provided.
Read the entire FDA prescribing information for Normocarb HF (Sterile Electrolyte Concentrate for Infusion) »
Additional Normocarb HF Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.